Dominion Aesthetic Technologies Announces FDA Clearance of eon™ FR, Non-Contact Body Sculpting
Retrieved on:
Tuesday, June 25, 2019
SAN ANTONIO, June 25, 2019 /PRNewswire/ -- Dominion Aesthetic Technologies, Inc. today announced that it has received FDA clearance for its body contouring product, eonFR, which is a non-contact medical device that reduces fat.
Key Points:
- SAN ANTONIO, June 25, 2019 /PRNewswire/ -- Dominion Aesthetic Technologies, Inc. today announced that it has received FDA clearance for its body contouring product, eonFR, which is a non-contact medical device that reduces fat.
- "I am very pleased that eon FR has received its FDA clearance demonstrating the safety and efficacy of our non-contact, medical device," says Janet Campbell, Founder, Chairman and CEO of Dominion Aesthetic Technologies, Inc."Clearance was secured thanks to our world-class team of laser engineers, scientists, physicist and our incredibly talented scientific advisers who contributed to the study of eon FR."
- "The clever engineering of eon FR might well make it the 'next big thing' for non-invasive body contouring," says Dr. Thomas Fiala, owner of Fiala Aesthetics.
- Dominion created eon FR, a platform technology, to offer the best tools with innovation to serve the physicians' practices and the patients' needs.